MindWalk Holdings Corp. (HYFT)
NASDAQ: HYFT · Real-Time Price · USD
1.270
+0.070 (5.83%)
May 8, 2026, 4:00 PM EDT - Market closed
MindWalk Holdings Revenue
MindWalk Holdings had revenue of 4.16M CAD in the quarter ending January 31, 2026, with 52.42% growth. This brings the company's revenue in the last twelve months to 28.08M, up 95.87% year-over-year. In the fiscal year ending April 30, 2025, MindWalk Holdings had annual revenue of 24.52M with 0.01% growth.
Revenue (ttm)
28.08M CAD
Revenue Growth
+95.87%
P/S Ratio
3.05
Revenue / Employee
275,333 CAD
Employees
102
Market Cap
63.08M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 24.52M | 2.00K | 0.01% |
| Apr 30, 2024 | 24.52M | 3.85M | 18.65% |
| Apr 30, 2023 | 20.67M | 1.30M | 6.72% |
| Apr 30, 2022 | 19.36M | 1.45M | 8.11% |
| Apr 30, 2021 | 17.91M | 3.85M | 27.41% |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Immutep | 5.28M |
| BeyondSpring | 1.88M |
| ImageneBio | 800.00K |
| MediciNova | 409.66K |
| iBio, Inc. | 300.00K |
| Entera Bio | 42.00K |
| Impact BioMedical | 32.00K |
HYFT News
- 25 days ago - MindWalk initiated with a Buy at JonesResearch - TheFly
- 2 months ago - MindWalk Holdings Earnings Call Transcript: Q3 2026 - Transcripts
- 2 months ago - MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results - Business Wire
- 2 months ago - MindWalk announces nanobody discovery platform - TheFly
- 2 months ago - MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era - Business Wire
- 2 months ago - MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026 - Business Wire
- 3 months ago - MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Business Wire
- 4 months ago - MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease - Business Wire